This press release contains dated information and should be used for background only.
KANSAS CITY, Kan. –It’s quite an honor for one of a hospital’s cardiology research studies to be presented at a national conference. At The University of Kansas Hospital, five studies from the heart team’s researchers will be presented at the American College of Cardiology’s annual conference in New Orleans, March 24-27.
“To have five abstracts accepted for a major cardiovascular meeting is outstanding,” said Jim Vacek, MD, Director of Cardiovascular Research at The University of Kansas Hospital. “This is something that even leading academic institutions would be proud of. It shows the increased growth in cardiovascular research at KU Hospital since the heart team was revitalized in 2001.”
The five studies to be presented are:
- Do Statins Improve Survival in Patients with Diastolic Dysfunction and Preserved Left Ventricular Ejection Fraction?
- Prognostic Significance of Dyspnea in patients Referred for Stress Echocardiography
- Severe Left Ventricular Dilation is Associated with Poor Long-term survival
- Carotid Artery Stenosis: Is It a Marker of Poor Prognosis?
- Gender and Severity of Left Ventricular Hypertrophy Predict Long-term Survival
“Research is a vital part of the mission of the heart team at The University of Kansas Hospital,” said Vacek. “Scholarly investigation is necessary for medicine to increase its fund of knowledge, to advance patient care and improve medical outcomes. It is necessary for our institution to engage in research to fulfill its destiny as an academic medical center. An academic medical center must provide the most state of the art medical care, bring new discoveries to patient management, and train the next generation of medical providers. These goals can be accomplished only when active, productive research is an integral component of the center’s program.”
Cardiologists from the University of Kansas Hospital will also present major research at the American Thoracic Society national meeting at San Francisco in May. Since 2001, cardiology researchers at The University of Kansas Hospital have published and presented their findings at 54 national and international conferences.
The University of Kansas Hospital is the region's premier academic medical center, providing a full range of care. The hospital was separated from the University of Kansas system and is governed by an independent Authority Board, which gives the hospital greater flexibility to respond to changes in patient care and technology. However, the hospital continues to be affiliated with the University of Kansas Schools of Medicine, Nursing and Allied Health, and their various leading edge research projects. The constantly growing facility contains more than 500 staffed beds and serves nearly 15,000 inpatients annually. Among The University of Kansas Hospital’s key clinical strengths are a comprehensive heart program, a leading neuroscience expertise in such areas as deep brain surgery and inter-disciplinary cancer program. For cancer treatment, The University of Kansas Hospital is the only hospital in the region that offers the combination PET, IMRT, and ACIS technology for diagnosis and treatment of cancer, the region's only burn center, the area's only nationally accredited Level I Trauma Center, and one of the nation's leading centers for polycystic kidney disease.